Cited by 1,141Schizophrenia research and treatmentNicotinic Acetylcholine Receptors StudyGenetic Associations and Epidemiology

The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

Open access

Freedman, Robert, Coon, Hilary, Myles-Worsley, Marina, Orr-Urtreger, Avi, Olincy, Ann, Davis, Ashley, Polymeropoulos, Mihael, Holik, John, Hopkins, Jan, Hoff, Mark, Rosenthal, Judy, Waldo, Merilyne C., Reimherr, Fred, Wender, Paul, Yaw, Jeffrey, Young, David A., Breese, Charles R., Adams, Catherine, Patterson, David, Adler, Lawrence E., Kruglyak, Leonid, Leonard, Sherry, Byerley, William·1997·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.94.2.587PMC PMC19557

Open this paper in CoChat — free account

Abstract

Inheritance of a defect in a neuronal mechanism that regulates response to auditory stimuli was studied in nine families with multiple cases of schizophrenia. The defect, a decrease in the normal inhibition of the P50 auditory-evoked response to the second of paired stimuli, is associated with attentional disturbances in schizophrenia. Decreased P50 inhibition occurs not only in most schizophrenics, but also in many of their nonschizophrenic relatives, in a distribution consistent with inherited vulnerability for the illness. Neurobiological investigations in both humans and animal models indicated that decreased function of the α7-nicotinic cholinergic receptor could underlie the physiological defect. In the present study, a genome-wide linkage analysis, assuming autosomal dominant transmission, showed that the defect is linked [maximum logarithm of the odds (lod) score = 5.3 with zero recombination] to a dinucleotide polymorphism at chromosome 15q13-14, the site of the α7-nicotinic receptor. Despite many schizophrenics’ extremely heavy nicotine use, nicotinic receptors were not previously thought to be involved in schizophrenia. The linkage data thus provide unique new evidence that the α7-nicotinic receptor gene may be responsible for the inheritance of a pathophysiological aspect of the illness.

Integrity signals

Registry

Crossref · 10.1073/pnas.94.2.587

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Research Diagnostic Criteria
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946
A Diagnostic Interview
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,686
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
Self-citation
Strategies for multilocus linkage analysis in humans.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3443 · Cited by 2,560
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX
Couturier, S., Bertrand, D., Matter, J., Hernandez, M., Bertrand, S., Millar, N. S., Valera, S., BARKAS, T., & Ballivet, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90344-f · Cited by 941
Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia.
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Self-citation

Flagged first, then by citations

Show all 63 references

1 of the 63 references couldn’t be matched to a known paper.

Research works printed but not linked: 8

J-M Lalouel Am J Hum Genet 37, 700–718 (1985).
L E Adler, E Pachtman, R Franks, M Pecevich, M C Waldo, R Freedman Biol Psychiatry 17, 639–654 (1982).
W R Goff, P D Williamson, C VanGilder, R Allison, T C Fisher Prog Clin Neurophysiol 7, 126–145 (1980).
L Kruglyak, M J Daly, M P Reeve-Daly, E S Lander Am J Hum Genet 58, 1347–1363 (1996).
L Kruglyak, E S Lander Am J Hum Genet 57, 519–527 (1995).
M Melissari, G Giordano, P Crafa, M Martella, R Ricci Pathologica 87, 78–81 (1995).
L K Casaubon, M Melanson, I Lopes-Cendes, C Marineau, E Andersmann, F Andersmann, J Weissenbach, C Prevost, J P Bouchard, J Matheiu, G A Rouleau Am J Hum Genet 58, 28–34 (1996).
10.1002/(SICI)1096-8628(19960409)67:2<154::AID-AJMG5>3.0.CO;2-S · DOI

Sorted by citations

Items 701–800 of 1,000

Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging
Smucny, J., & Tregellas, J. R. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117705071 · Cited by 21
Association between the 2-bp deletion polymorphism in the duplicated version of the alpha7 nicotinic receptor gene and P50 sensory gating
Flomen, R. H., Shaikh, M., Walshe, M., Schulze, K., Hall, M., Picchioni, M., Rijsdijk, F. V., Toulopoulou, T., Kravariti, E., Murray, R. M., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.81 · Cited by 21
Nicotine use in patients with schizophrenia evaluated by the Fagerström Tolerance Questionnaire: a descriptive analysis from a Brazilian sample
Chaves, L. P., & Shirakawa, I. (2008) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462008005000014 · Cited by 21
Handbook of neurochemistry and molecular neurobiology, schizophrenia
Lajtha, Á., Javitt, D. C., & Kantrowitz, J. T. (2009) · Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) · doi:10.1007/978-0-387-30410-6 · Cited by 21
Molecular genetics of schizophrenia: a review of the recent literature
Levinson, D. F. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200303000-00004 · Cited by 21
Decreased Bombesin Peptide Response to Cigarette Smoking in Schizophrenia
D, A. O. M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00053-0 · Cited by 21
Finding Genes for Bipolar Disorder in the Functional Genomics Era: From Convergent Functional Genomics to Phenomics and Back
Niculescu, A. B., & Kelsoe, J. R. (2002) · CNS Spectrums · doi:10.1017/s1092852900017582 · Cited by 21
Summary of research prepared by Steven Moldin, NIMH
(1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00069-4 · Cited by 21
The epidemiology of the genetic liability for schizophrenia
Hallmayer, J. F. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00769.x · Cited by 21
An initial report of a new biological marker for bipolar disorder: P85 evoked brain potential
Patterson, J. V., Sandman, C. A., Ring, A., Jin, Y., & Bunney, W. E. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00734.x · Cited by 20
Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia
Choueiry, J., Blais, C. M., Shah, D. K., Smith, D., Fisher, D. J., Labelle, A., & Knott, V. (2019) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2019.02.005 · Cited by 20
Neurocognitive functioning and schizophrenia spectrum disorders can be independent expressions of familial liability for schizophrenia in community control children: the UCLA family study
Asarnow, R. F., Nuechterlein, K. H., Asamen, J. K., Fogelson, D. L., Subotnik, K. L., Zaucha, K., & Guthrie, D. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00358-9 · Cited by 20
Functional and molecular characterization of neuronal nicotinic ACh receptors in rat hippocampal interneurons
Yakel, J. L., & Shao, Z. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45006-1 · Cited by 20
Facilitation of Dopamine-Mediated Locomotor Activity in Adult Rats following Cholinergic Denervation
Mattsson, A., Ögren, S. O., & Olson, L. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7850 · Cited by 20
Sensory gating in intracranial recordings — The role of phase locking
Rosburg, T., Trautner, P., Fell, J., Moxon, K. A., Elger, C. E., & Boutros, N. N. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.09.035 · Cited by 20
The Epidemiology of the Genetic Liability for Schizophrenia
Hallmayer, J. F. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/000486700222 · Cited by 20
Connecting the "Dots" of Brain Dysfunction in Schizophrenia
Braff, D. L. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.791 · Cited by 20
A critical overview of recent investigations into the genetics of schizophrenia
DeLisi, L. E. (1999) · Current Opinion in Psychiatry · doi:10.1097/00001504-199901000-00014 · Cited by 20
Maternal Prenatal Depression in Pregnancies With Female and Male Fetuses and Developmental Associations With C-reactive Protein and Cortisol
Freedman, R., Hunter, S. K., Noonan, K., Wyrwa, A., Christians, U., Law, A. J., & Hoffman, M. C. (2021) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.08.003 · Cited by 19
Self-citation
Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism
Wildeboer, K. M., Zheng, L., Choo, K. S., & Stevens, K. E. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.075 · Cited by 19
Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis
Kohlhaas, K. L., Bitner, R. S., Gopalakrishnan, M., & Rueter, L. E. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2535-6 · Cited by 19
Exploring the relationships between tobacco smoking and schizophrenia in first-degree relatives
Ferchiou, A., Szöke, A., Laguerre, A., Méary, A., Leboyer, M., & Schürhoff, F. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.07.054 · Cited by 19
Effect of short-term exposure to dichlorvos on synaptic plasticity of rat hippocampal slices: Involvement of acylpeptide hydrolase and α7 nicotinic receptors
Olmos, C., Sandoval, R., Rozas, C., Navarro, S., Wyneken, Ú., Zeise, M. L., Morales, B., & Pancetti, F. C. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.04.011 · Cited by 19
Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine‐Δ2‐Isoxazoline Scaffold: Synthesis and Electrophysiological Evaluation
Quadri, M., Matera, C., Silnović, A., Pismataro, M. C., Horenstein, N. A., Stokes, C. A., Papke, R. L., & Dallanoce, C. (2017) · ChemMedChem · doi:10.1002/cmdc.201700162 · Cited by 19
A Research Agenda For DSM-V
First, M. B., & Regier, D. A. (2002) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890427644 · Cited by 19
P50 sensory gating deficit in children with centrotemporal spikes and sharp waves in the EEG
Fiedler, B. J., Debus, O. M., Neubauer, B. A., Kienle, M., & Kurlemann, G. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.071 · Cited by 19
Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions.
Tizabi, Y., & Getachew, B. (2017) · PubMed · Cited by 19
Some properties of human neuronal α7 nicotinic acetylcholine receptors fused to the green fluorescent protein
Palma, E., Mileo, A. M., Martínez‐Torres, A., Eusebi, F., & Miledi, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052699299 · Cited by 19
Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment
Lee, A. M., & Tyndale, R. F. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066039 · Cited by 19
Interaction of corticosterone and nicotine in regulation of prepulse inhibition in mice
Ingram, N., Martin, S., Wang, J. H., van der Laan, S., Loiacono, R. E., & van den Buuse, M. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.015 · Cited by 19
Increased hippocampal volume in schizophrenics' parents with ancestral history of schizophrenia
Harris, J. G., Young, D. A., Rojas, D. C., Cajade-Law, A. G., Scherzinger, A. L., Nawroz, S., Adler, L. E., Cullum, C. M., Simon, J. H., & Freedman, R. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00272-9 · Cited by 19
Self-citation
Dopamine receptors and schizophrenia: contribution of molecular genetics and clinical neuropsychology
Emilien, G., Maloteaux, J., Geurts, M., & Owen, M. J. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001479 · Cited by 19
α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease~!2009-10-15~!2009-10-30~!2010-05-27~!
Toyohara, J., & Hashimoto, K. (2010) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501004020037 · Cited by 18
CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models
Barazesh, M., Mohammadi, S., Bahrami, Y., Mokarram, P., Morowvat, M. H., Saidijam, M., Karimipoor, M., Kavousipour, S., Vosoughi, A. R., & Khanaki, K. (2020) · Current Gene Therapy · doi:10.2174/1566523220666201214115024 · Cited by 19
Mouse models for studying genetic influences on factors determining smoking cessation success in humans
Hall, F. S., Markou, A., Levin, E. D., & Uhl, G. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06415.x · Cited by 18
Varenicline use in patients with mental illness: an update of the evidence
Purvis, T. L., Nelson, L. A., & Mambourg, S. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740331003657133 · Cited by 19
Phenotype mining in CNV carriers from a population cohort †
Pietiläinen, O. P. H., Rehnström, K., Jakkula, E., Service, S. K., Congdon, E. L., Tilgmann, C., Hartikainen, A., Taanila, A. M., Heikura, U., Paunio, T., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr162 · Cited by 18
Smoking initiation and schizophrenia: A replication study in a Chinese Han population
Zhang, X., Li, C. B., Li, M., Zheng, Y. L., Zhang, C. X., Yan, Q. Z., Liu, W. Z., Kang, Y. M., Wang, F., Chen, D. C., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.11.012 · Cited by 18
The potential of nicotinic enhancement of cognitive remediation training in schizophrenia
Hahn, B., Gold, J. M., & Buchanan, R. W. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.050 · Cited by 18
α7 Nicotinic Receptor Gene Promoter Polymorphisms in Inbred Mice Affect Expression in a Cell Type-specific Fashion
Mexal, S., Jenkins, P. M., Lautner, M. A., Iacob, E., Crouch, E. L., & Stitzel, J. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610694200 · Cited by 18
Epidemiology of Comorbid Tobacco Use and Schizophrenia: Thinking About Risks and Protective Factors
de León, J., Gurpegui, M., & Díaz, F. J. (2007) · Journal of Dual Diagnosis · doi:10.1300/j374v03n03_03 · Cited by 18
Regulation of epileptiform activity in hippocampus by nicotinic acetylcholine receptor activation
Roshan‐Milani, S., Ferrigan, L., Khoshnoud, M. J., Davies, C. H., & Cobb, S. (2003) · Epilepsy Research · doi:10.1016/j.eplepsyres.2003.08.005 · Cited by 18
Naturally occurring genetic variability in the nicotinic acetylcholine receptor alpha4 and alpha7 subunit genes and phenotypic diversity in humans and mice
Stitzel, J. A. (2007) · Frontiers in bioscience · doi:10.2741/2694 · Cited by 18
Chapter 1. Basic Nomenclature Issues for DSM-V
Rounsaville, B. J., Alarcón, R. D., Andrews, G., Jackson, J. S., Kendell, R. E., & Kendler, K. S. (2002) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890427644.lg01 · Cited by 18
Loss of cortical acetylcholine enhances amphetamine-induced locomotor activity
Mattsson, A., Pernold, K., Ögren, S. O., & Olson, L. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.038 · Cited by 18
Biological phenotypes and genetic research on schizophrenia.
Weinberger, D. R. (2002) · PubMed · Cited by 18
Nicotinic antagonist α-bungarotoxin binding to rat hippocampal neurons containing nitric oxide synthase
Adams, C. E., & Freedman, R. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00978-5 · Cited by 18
Self-citation
Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs
Kombo, D. C., Mazurov, A. A., Chewning, J., Hammond, P. S., Tallapragada, K., Hauser, T. A., Speake, J. D., Yohannes, D., & Caldwell, W. S. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.11.090 · Cited by 17
Genetic mapping of putative Chrna7 and Luzp2 neuronal transcriptional enhancers due to impact of a transgene-insertion and 6.8 Mb deletion in a mouse model of Prader-Willi and Angelman syndromes
Stefan, M., Claiborn, K. C., Stasiek, E., Chai, J., Ohta, T., Longnecker, R., Greally, J. M., & Nicholls, R. D. (2005) · BMC Genomics · doi:10.1186/1471-2164-6-157 · Cited by 17
The Multi-Circuit Neuronal Hyperexcitability Hypothesis of Psychiatric Disorders
Binder, M. (2019) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20190701.13 · Cited by 13
Cotinine impacts sensory processing in DBA/2 mice through changes in the conditioning amplitude
Wildeboer, K. M., Zheng, L., Choo, K. S., & Stevens, K. E. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.12.005 · Cited by 17
Using rodents to model schizophrenia and substance use comorbidity
Ng, E., McGirr, A., Wong, A. H. C., & Roder, J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.025 · Cited by 19
Neurological abnormalities and neurocognitive functions in healthy elder people: A structural equation modeling analysis
Chan, R. C. K., Xu, T., Li, H.-J., Zhao, Q., Liu, H.-H., Wang, Y., Yan, C., Cao, X.-Y., Wang, Y.-N., Shi, Y.-F., et al. (2011) · Behavioral and Brain Functions · doi:10.1186/1744-9081-7-32 · Cited by 17
Transcriptional Repression of the α7 Nicotinic Acetylcholine Receptor Subunit Gene (CHRNA7) by Activating Protein-2α (AP-2α)
Finlay-Schultz, J., Canastar, A., Short, M., Gazzar, M. E., Coughlan, C. M., & Leonard, S. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276014 · Cited by 17
Self-citation
Disruption of sensory gating by moderate alcohol doses
Sklar, A. L., & Nixon, S. J. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3591-5 · Cited by 17
The Role of Nicotinic Receptors in the Attenuation of Autism‐Related Behaviors in a Murine BTBR T + tf/J Autistic Model
Mahmood, H. M., Aldhalaan, H., Alshammari, T. K., Alqasem, M., Alshammari, M. A., Albekairi, N. A., & AlSharari, S. D. (2020) · Autism Research · doi:10.1002/aur.2342 · Cited by 17
Identification and in vitro pharmacological characterization of a novel and selective α7 nicotinic acetylcholine receptor agonist, Br-IQ17B
Tang, J., Xie, B., Bian, X., Xue, Y., Wei, N., Zhou, J., Hao, Y., Li, G., Zhang, L., & Wang, K.-W. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.9 · Cited by 17
Similar effect of family history of psychosis on Sylvian fissure size and auditory P200 amplitude in schizophrenic and bipolar subjects
Tabarés‐Seisdedos, R., Balanzá‐Martínez, V., Pallardó, Y., Salazar-Fraile, J., Selva, G., Vilela, C., Vallet, M., Leal, C., & Gómez-Beneyto, M. (2001) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(01)00113-5 · Cited by 17
The effect of nicotine and haloperidol co-treatment on nicotinic receptor levels in the rat brain
Lee, M. J., Breese, C. R., Strook, M. L., & Leonard, S. S. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00274-6 · Cited by 17
Self-citation
Defining the schizophrenia phenotype
Thaker, G. K. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0022-6 · Cited by 17
Lithium alters measures of auditory gating in two strains of mice
O’Neill, H. C., Schmitt, M. P., & Stevens, K. E. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00184-7 · Cited by 17
The Continuous Performance Test, Identical Pairs: norms, reliability and performance in healthy controls and patients with schizophrenia in Singapore
Rapisarda, A., Kraus, M., Tan, Y. W., Lam, M., Eng, G. K., Lee, J., Subramaniam, M., Collinson, S. L., Chong, S. A., & Keefe, R. S. E. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.016 · Cited by 16
Effects of restraint and haloperidol on sensory gating in the midbrain of awake rats
Anstrom, K. K., Cromwell, H. C., & Woodward, D. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.060 · Cited by 16
A two-stage linkage analysis of Chinese schizophrenia pedigrees in 10 target chromosomes
Zheng, Y., Wang, X., Gu, N., Feng, G., Zou, F., Qin, W. D., Zhang, J., Lin, W., Tao, R., Qian, X., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.041 · Cited by 16
Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats
Breier, M. R., Lewis, B. D., Shoemaker, J. M., Light, G. A., & Swerdlow, N. R. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.037 · Cited by 16
Dopamine D2 and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area
Garzón, M., Duffy, Á., Chan, J., Lynch, M., Mackie, K., & Pickel, V. M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.008 · Cited by 16
Differentiating nicotine- versus schizophrenia-associated decreases of the α7 nicotinic acetylcholine receptor transcript, CHRFAM7A, in peripheral blood lymphocytes
Severance, E. G., Dickerson, F., Stallings, C. R., Origoni, A. E., Sullens, A., Monson, E. T., & Yolken, R. H. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0164-y · Cited by 16
Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation
Ross, R. G., & Freedman, R. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv054 · Cited by 15
Self-citation
A Diagnostic Model Incorporating P50 Sensory Gating and Neuropsychological Tests for Schizophrenia
Shan, J., Liu, C., Chiu, M., Liu, C., Chien, Y., Hwang, T., Lin, Y., Hsieh, M. H., Jaw, F., & Hwu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057197 · Cited by 15
Peripheral DISC1 protein levels as a trait marker for schizophrenia and modulating effects of nicotine
Trossbach, S. V., Fehsel, K., Henning, U., Winterer, G., Luckhaus, C., Schäble, S., Silva, M. A. D. S., & Korth, C. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.064 · Cited by 15
Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain
Sharma, G., & Vijayaraghavan, S. (2008) · Substance Abuse Research and Treatment · doi:10.1177/117822180800100005 · Cited by 16
Sensory gating deficits in the attenuated psychosis syndrome
Shaikh, M., Dutt, A., Broome, M. R., Vozmediano, A. G., Ranlund, S. M., Díez, Á., Caseiro, O., Lappin, J., Amankwa, S., Carletti, F., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.021 · Cited by 15
Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: Development of a selective α7 nicotinic acetylcholine receptor agonist strategy
Deutsch, S. I., Rosse, R. B., Schwartz, B. L., Schooler, N. R., Gaskins, B. L., Long, K. D., & Mastropaolo, J. P. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.05.008 · Cited by 15
Genetic Association Study of the Alpha 7 Nicotinic Receptor ( CHRNA7 ) with the Development of Schizophrenia and Bipolar Disorder in Korean Population
Joo, E.-J., Lee, K. Y., Kim, H. S., Kim, S. H., Ahn, Y. M., & Kim, Y. S. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.3.196 · Cited by 15
Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats
Wiker, C., Schilström, B., Sandbäck, C., Wadenberg, M.-L. G., & Svensson, T. H. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008730 · Cited by 15
Promoter IV ‐ BDNF deficiency disturbs cholinergic gene expression of CHRNA 5, CHRM 2, and CHRM 5: effects of drug and environmental treatments
Sakata, K., & Overacre-Delgoffe, A. E. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14129 · Cited by 16
Neural correlates of sensory gating in the rat: decreased Fos induction in the lateral septum
van Luijtelaar, G., Fabene, P. F., de Bruin, N. M. W. J., Jongema, C., Ellenbroek, B. A., & Veening, J. G. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00430-5 · Cited by 16
Cortical cholinergic deficiency enhances amphetamine-induced dopamine release in the accumbens but not striatum
Mattsson, A., Olson, L., Svensson, T. H., & Schilström, B. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.012 · Cited by 15
N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an α7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate
Zanaletti, R., Bettinetti, L., Castaldo, C., Ceccarelli, I., Cocconcelli, G., Comery, T. A., Dunlop, J., Genesio, E., Ghiron, C., Haydar, S. N., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3013568 · Cited by 14
Structure–activity relationship studies of SEN12333 analogues: Determination of the optimal requirements for binding affinities at α7 nAChRs through incorporation of known structural motifs
Beinat, C., Reekie, T. A., Banister, S. D., O’Brien-Brown, J., Xie, T., Olson, T. T., Xiao, Y., Harvey, A. J., O'Connor, S. M., Coles, C. J., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.025 · Cited by 14
Co-occurrence of Marfan syndrome and schizophrenia: What can be learned?
Bossche, M. J. A. V. D., Wallendael, K. L. P. V., Stražišar, M., Sabbe, B., & Del‐Favero, J. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.02.005 · Cited by 14
Abnormal auditory sensory gating-out in first-episode and never-medicated paranoid schizophrenia patients: an fMRI study
Ji, B., Mei, W., Zhang, J. X., Jing, J., Wu, Q., Zhuo, Y., & Xiao, Z. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3600-7 · Cited by 14
Nicotinic acetylcholine receptor ligands as potential therapeutics
Gündisch, D. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.9.1221 · Cited by 14
Genes in families: attitudes toward genetic testing for schizophrenia
Coors, M. E. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.026 · Cited by 14
Contributions of molecular biology to antipsychotic drug discovery: promises fulfilled or unfulfilled?
Roth, B. L. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.3/broth · Cited by 14
Nicotine Addiction: Past and Present
Office on Smoking (2010) · Cited by 14
Chapter 3. Advances in Developmental Science and DSM-V
Pine, D. S., Alegria, M. M., Cook, E. H., Costello, E. J., Dahl, R. E., Koretz, D. S., Merikangas, K. R., Reiss, A. L., & Vitiello, B. (2002) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890427644.lg03 · Cited by 14
The Membrane Phospholipid Concept of Schizophrenia
Horrobin, D. F., & Bennett, C. N. (1999) · Steinkopff eBooks · doi:10.1007/978-3-642-47076-9_19 · Cited by 14
Clinical Aspects of Nicotinic Agents: Therapeutic Applications in Central Nervous System Disorders
NEWHOUSE, P. A., & Kelton, M. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_26 · Cited by 14
Genetics of Psychosis in Alzheimer Disease
DeMichele‐Sweet, M. A. A., & Sweet, R. A. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0030-1 · Cited by 13
P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients
Turetsky, B. I., Dent, G. W., Jaeger, J., & Zukin, S. R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2544-5 · Cited by 13
Association of functional dopamine-beta-hydroxylase (DBH) 19bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers
Zhang, X., Chen, D. C., Xiu, M. H., Hui, L., Liu, H., Luο, X., Zuo, L., Zhang, H., Kosten, T. A., & Kosten, T. R. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.07.011 · Cited by 14
Re-visiting the nature and relationships between neurological signs and neurocognitive functions in first-episode schizophrenia: An invariance model across time
Chan, R. C. K., Dai, S., Lui, S. S. Y., Ho, K. K. Y., Hung, K. S. Y., Wang, Y., Geng, F., Li, Z., & Cheung, E. F. C. (2015) · Scientific Reports · doi:10.1038/srep11850 · Cited by 13
Transmission disequilibrium analysis of the GSN gene in a cohort of family trios with schizophrenia
Xi, Z., Qin, W. D., Yang, Y., He, G., Gao, S., Ren, M., Peng, Y. W., Zhang, Z., & He, L. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.041 · Cited by 13
Poids de la comorbidité addictive dans le risque d’observance partielle au traitement médicamenteux et de rechute dans la schizophrénie
Ameller, A., & Gorwood, P. A. P. M. (2015) · L Encéphale · doi:10.1016/j.encep.2015.02.002 · Cited by 13
Warum rauchen Schizophreniepatienten?
Cattapan-Ludewig, K., Ludewig, S., Sirot, E. J., Etzensberger, M., & Hasler, F. (2004) · Der Nervenarzt · doi:10.1007/s00115-004-1818-0 · Cited by 13
Pharmacological characterization of JWX-A0108 as a novel type I positive allosteric modulator of α7 nAChR that can reverse acoustic gating deficits in a mouse prepulse inhibition model
Sun, L., Yang, T., Wei, N., Lu, W., Jiao, W., Zhou, Q., Miao, Y., Gao, Q. F., Wang, X., Sun, Q. L., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0163-y · Cited by 13
Recent progress in the neurotoxicology of natural drugs associated with dependence or addiction, their endogenous agonists and receptors.
Kobayashi, H., Suzuki, T., Kamata, R., Saito, S., Sato, I., Tsuda, S., & Matsusaka, N. (1999) · The Journal of Toxicological Sciences · doi:10.2131/jts.24.1 · Cited by 13
Population-based and family-based association studies of an (AC)n dinucleotide repeat in α-7 nicotinic receptor subunit gene and schizophrenia
Fan, J., Ma, J., Li, X.-W., Zhang, C.-S., Sun, W.-W., He, G., Gu, N., Feng, G.-Y., Clair, D. S., & He, L. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.02.012 · Cited by 13
Animal Models of Psychosis
Deutsch, S. I., Long, K. D., Rosse, R. B., Tizabi, Y., Weizman, R., Eller, J., & Mastropaolo, J. P. (2006) · Contemporary clinical neuroscience · doi:10.1007/978-1-59745-058-4_10 · Cited by 13

Authors: Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M. C., Reimherr, F., Wender, P., Yaw, J., Young, D. A., Breese, C. R., Adams, C., Patterson, D., Adler, L. E., Kruglyak, L., Leonard, S., & Byerley, W.
Affiliations: Baylor College of Medicine (US)
Departments of Psychiatry, Pharmacology, Biochemistry, and Preventive Medicine and Biophysics, University of Colorado School of Medicine, Denver Veterans Affairs Medical Center, and Eleanor Roosevelt Institute for Cancer Research, Denver, CO 80262; Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT 84132; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030-3498; National Center for Human Genome Research/National Institutes of...
ORCID: Freedman, Robert
Coon, Hilary
Polymeropoulos, Mihael
Young, David A.
Breese, Charles R.
Patterson, David
Kruglyak, Leonid
Byerley, William
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1997-01-21
Volume: 94
Issue: 2
Pages: 587-592
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.94.2.587
PMC: PMC19557
OpenAlex: W2144671685
Cited by: 1,141
References: 63
Citations by year: 2026: 3 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 16 · 2019: 15 · 2018: 6 · 2017: 14 · 2016: 19 · 2015: 46 · 2014: 25 · 2013: 28 · 2012: 39
FWCI: 62.17
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Veterans Affairs
National Institutes of Health (5k02mh001089-03, 1f32mh010168-01, DA09457)
National Institute on Aging (T32AG000029)
National Institute of Mental Health (MH-44212, P50MH044212, MH01089, MH-10168-F32)
National Institute on Drug Abuse (R01DA009457)
National Center for Research Resources (P41RR003655, M01RR000064)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: schizophrenia, alpha7 nicotinic acetylcholine receptor, genetic linkage, autosomal dominant inheritance, attention deficits, family-based genetic study, nicotine use
MeSH terms: Auditory Perception, Chromosomes, Human, Pair 15, Evoked Potentials, Female, Genes, Genetic Markers, Humans, Genetic Linkage, Male, Pedigree, Receptors, Nicotinic, Schizophrenia, Chromosomes, Artificial, Yeast

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks